International audienceWe present a computational method, TuMult, for reconstructing the sequence of copy number changes driving carcinogenesis, based on the analysis of several tumor samples from the same patient. We demonstrate the reliability of the method with simulated data, and describe applications to three different cancers, showing that TuMult is a valuable tool for the establishment of clonal relationships between tumor samples and the identification of chromosome aberrations occurring at crucial steps in cancer progression
Genomic aberrations such as copy number alterations (CNA) and loss of heterozygosity (LOH) are hallm...
Clonal deconvolution of mutational landscapes is crucial to understand the evolutionary dynamics of ...
Die Intra-Tumor-Heterogenität spiegelt eine kontinuierliche Entwicklung zwischen den Zellen eines ei...
International audienceWe present a computational method, TuMult, for reconstructing the sequence of ...
Tumour development has long been recognised as an evolutionary process during which cells accumulate...
By accurately describing cancer genomes, we may link genomic mutations to phenotypic effects and eve...
Tumour heterogeneity is central to chemotherapy resistance and disease progression in advanced malig...
Knowledge about the clonal evolution of a tumor can help to interpret the function of its genetic al...
Cancer is a genetic disease. The activation, alteration or deactivation of cancer genes can stimulat...
SummaryThe extensive genetic heterogeneity of cancers can greatly affect therapy success due to the ...
Study of DNA copy-number variation is a key part of cancer genomics. With the help of a comprehensiv...
*To whom correspondence should be addressed. Motivation: Phylogenetic algorithms have begun to see w...
Cancer is an evolutionary process involving the accumulation of somatic mutations in the genome. The...
Genomic analysis provides insights into the role of copy number variation in disease, but most metho...
Tumours accumulate many somatic mutations in their lifetime. Some of these mutations, drivers, conve...
Genomic aberrations such as copy number alterations (CNA) and loss of heterozygosity (LOH) are hallm...
Clonal deconvolution of mutational landscapes is crucial to understand the evolutionary dynamics of ...
Die Intra-Tumor-Heterogenität spiegelt eine kontinuierliche Entwicklung zwischen den Zellen eines ei...
International audienceWe present a computational method, TuMult, for reconstructing the sequence of ...
Tumour development has long been recognised as an evolutionary process during which cells accumulate...
By accurately describing cancer genomes, we may link genomic mutations to phenotypic effects and eve...
Tumour heterogeneity is central to chemotherapy resistance and disease progression in advanced malig...
Knowledge about the clonal evolution of a tumor can help to interpret the function of its genetic al...
Cancer is a genetic disease. The activation, alteration or deactivation of cancer genes can stimulat...
SummaryThe extensive genetic heterogeneity of cancers can greatly affect therapy success due to the ...
Study of DNA copy-number variation is a key part of cancer genomics. With the help of a comprehensiv...
*To whom correspondence should be addressed. Motivation: Phylogenetic algorithms have begun to see w...
Cancer is an evolutionary process involving the accumulation of somatic mutations in the genome. The...
Genomic analysis provides insights into the role of copy number variation in disease, but most metho...
Tumours accumulate many somatic mutations in their lifetime. Some of these mutations, drivers, conve...
Genomic aberrations such as copy number alterations (CNA) and loss of heterozygosity (LOH) are hallm...
Clonal deconvolution of mutational landscapes is crucial to understand the evolutionary dynamics of ...
Die Intra-Tumor-Heterogenität spiegelt eine kontinuierliche Entwicklung zwischen den Zellen eines ei...